Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
misiu143's Profile
Displaying 101-150 of 4550 result(s).
CYDY CytoDyn Inc
05/14/2025 12:16:05 PM
Yes , very much yes,, About 50% of (10)
CYDY CytoDyn Inc
05/14/2025 12:30:36 AM
One cycle is 21 days.. (1)
CYDY CytoDyn Inc
05/13/2025 8:01:33 PM
Schwab gave me a little different (2)
CYDY CytoDyn Inc
05/13/2025 3:51:19 PM
There were 3 preclinical studies do (15)
CYDY CytoDyn Inc
05/12/2025 11:18:33 AM
I agree with you Jeff . Treating so (20)
CYDY CytoDyn Inc
05/08/2025 1:09:00 PM
Great post from IHUB.. easy explana (26)
CYDY CytoDyn Inc
05/08/2025 9:21:46 AM
Right , and 3-4 years later , we st (9)
CYDY CytoDyn Inc
05/08/2025 9:08:45 AM
Biloxi, And I will always think ver (20)
CYDY CytoDyn Inc
05/08/2025 8:55:16 AM
I am sure you know , all of those p (11)
CYDY CytoDyn Inc
05/08/2025 8:26:00 AM
Well , sorry .. Great .. I actually (7)
CYDY CytoDyn Inc
05/08/2025 7:31:49 AM
Ohm , thank you for all the great a (20)
CYDY CytoDyn Inc
05/08/2025 6:55:33 AM
Ken this is exactly right , because (7)
CYDY CytoDyn Inc
05/08/2025 6:45:53 AM
I can’t give you numbers , but im (9)
CYDY CytoDyn Inc
05/07/2025 5:47:24 PM
What I know dostarlimab is mostly t (11)
CYDY CytoDyn Inc
05/07/2025 3:05:17 PM
Glioblastoma , imo , is not yet con (9)
CYDY CytoDyn Inc
05/07/2025 1:53:59 PM
Katangolo , we will have most proba (30)
CYDY CytoDyn Inc
05/07/2025 7:44:17 AM
They both looking on a different th (6)
CYDY CytoDyn Inc
05/07/2025 7:21:08 AM
Ohm , Protocol for a trial may go f (4)
CYDY CytoDyn Inc
05/06/2025 2:44:18 PM
December 2024, " .protocol is final (2)
CYDY CytoDyn Inc
05/06/2025 2:20:42 PM
Sean , it would be OK , most probab (2)
CYDY CytoDyn Inc
05/06/2025 12:41:24 PM
I was in Central NJ , went to Balti (13)
CYDY CytoDyn Inc
05/06/2025 11:20:52 AM
Ohm, I only know the facts I am rea (15)
CYDY CytoDyn Inc
05/06/2025 10:55:40 AM
Ken , all what is important now for (3)
CYDY CytoDyn Inc
05/06/2025 10:28:51 AM
And from March of 2025 letter .. " (9)
CYDY CytoDyn Inc
05/06/2025 9:37:21 AM
That is not really important , our (4)
CYDY CytoDyn Inc
05/06/2025 9:28:12 AM
Hi Biloxi , late but we are hopeful (7)
CYDY CytoDyn Inc
05/06/2025 9:24:21 AM
No Ken I cant agree here ... They c (5)
CYDY CytoDyn Inc
05/06/2025 9:18:25 AM
That is exactly right , taking 15 m (5)
CYDY CytoDyn Inc
05/06/2025 9:07:18 AM
Yes , but Cornell is not paying for (7)
CYDY CytoDyn Inc
05/06/2025 8:30:13 AM
Ohm, what Gov has to do with our Al (13)
CYDY CytoDyn Inc
04/30/2025 1:44:02 PM
Great question , and a comments .. (6)
CYDY CytoDyn Inc
04/29/2025 3:25:54 PM
Exactly mTNBC ...
CYDY CytoDyn Inc
04/29/2025 3:01:55 PM
I believe all patients we treat wit (2)
CYDY CytoDyn Inc
04/29/2025 10:53:29 AM
True, In our phase 1b/2 trial , fir (12)
CYDY CytoDyn Inc
04/29/2025 10:17:01 AM
28 patients. --10 patients from our (13)
CYDY CytoDyn Inc
04/16/2025 4:06:42 PM
I am very surprised Europe approved (12)
CYDY CytoDyn Inc
04/03/2025 6:20:07 PM
Your logic I do understand , but ye (1)
CYDY CytoDyn Inc
04/03/2025 2:23:41 PM
Yes , just one thing... We the only (16)
CYDY CytoDyn Inc
04/01/2025 6:43:18 PM
I knew that , working for some phar (3)
CYDY CytoDyn Inc
04/01/2025 6:30:54 PM
Few hrs ago I send an email to Dr J (10)
CYDY CytoDyn Inc
04/01/2025 6:24:56 PM
You are right , team should never m (1)
CYDY CytoDyn Inc
04/01/2025 5:07:31 PM
Cardamine , I am much more hopeful (4)
CYDY CytoDyn Inc
04/01/2025 4:53:41 PM
It is hard to believe Dr Jeff Murra (26)
CYDY CytoDyn Inc
04/01/2025 4:26:11 PM
I too am very excited to have Dr Ma (16)
CYDY CytoDyn Inc
04/01/2025 12:04:02 PM
True , company is providing informa (3)
CYDY CytoDyn Inc
04/01/2025 10:59:49 AM
Actually it is written phase 2 , an (2)
CYDY CytoDyn Inc
04/01/2025 10:50:35 AM
How is this possible ? we didn’t (3)
CYDY CytoDyn Inc
04/01/2025 10:41:39 AM
Clinical trials.gov says phase 2 fo (2)
CYDY CytoDyn Inc
03/30/2025 10:44:27 AM
This is an official poster presenta (13)
CYDY CytoDyn Inc
03/30/2025 10:04:13 AM
They should publish results from th (11)
Go to page:
  • << First
  • < Previous
  • 2
  • 3
  • Next >

Recent Articles

  • Analyst Perspectives on Integral Ad Science: A Thorough Review
  • Market Insights on Tetra Technologies: What Analysts Predict
  • Top Data Loss Prevention Solutions to Safeguard Business Data
  • Asheville Named the Friendliest Place in America for 2025
  • HMH Earns Esteemed Finalist Position in CODiE Awards 2025
  • Opportunity for Savara Inc. Shareholders to Address Losses
  • SEO Agency Malaysia Excels in Driving Online Business Growth
  • Comcast Advances AI to Enhance Internet Connectivity and Security
  • Treasure Global Welcomes Michael Chan as New Executive Director
  • Analyzing APA Inc's Current Market Position and Valuation
  • Market Insights on Recent ALAB Option Activities and Trends
  • Investors Show Strong Interest in BlackRock Options Activity
  • Ciena Options Activity Insights: What's Driving the Market?
  • Fuel Your Day with Gregorys Coffee's New Protein Buzz Drink
  • Transforming Transportation: NIBS Introduces BIM Transportation Library
  • Celebrating Innovators in Safety: Verkada’s 2025 Heroes
  • Opal Homes Group Expands Operations to Croatia and Beyond
  • Treasure Global Enhances Board with Michael Chan Appointment
  • McEwen Copper Secures Major Investment Opportunity in Argentina
  • Understanding Recent Trends for Opendoor Technologies (OPEN)
  • Bipartisan Mayors Unite to Combat Political Violence and Promote Civility
  • Market Update: Nasdaq Rises as Economic Sentiments Shift
  • Jefferies Financial Prepares for Earnings; Analyst Insights
  • Empowering Black Communities: Insights from a National Town Hall
  • FluidAI Medical's Origin™ Device Revolutionizes Post-Op Care
  • Tradewind Finance Fuels Growth for Bubble Tea Innovator
  • MAC.BID Expands with New Auction Venue and Bins Store
  • Elements Massage Celebrates Skin Care Awareness Month with Tips
  • Settlement of Digital Coupon Patent Dispute between Inmar & Neptune
  • SJE Inc. Celebrates Anniversary with Revere Control Systems
  • Join the Celebration: Celebree School Opens in Wayne Area
  • Ninepoint Partners Reveals Cash Distribution for September 2025
  • Membrane Bioreactor Market Expected to Skyrocket by 2030
  • SWIFT Embraces Ethereum's Linea for Game-Changing Pilot
  • Ensurge Micropower: Advancements in Innovative Battery Technology
  • IREN Ltd Faces Market Pressure After Downgrade: Insights
  • Caisse Française de Financement Local’s Latest Social Bond Issuance
  • Fisher House Foundation Opens New Facility to Aid Veterans
  • HNI Corporation Launches Significant Restructuring Initiative
  • Analyst Predicts Bitcoin May Exceed $130,000 by Year-End
  • Toll Brothers to Open Exclusive Luxury Community in Las Vegas
  • Quantum Computing Stocks on the Rise Amid Positive Forecasts
  • Legal Troubles Loom for Pfizer Amid Depo-Provera Controversy
  • Amgen's $650 Million U.S. Manufacturing Expansion Plan
  • LaFleur Minerals Inc. Positioned to Benefit from Gold Surge
  • Ethos Announces Registration for Initial Public Offering
  • ING's Strategic Exit from the Russian Market and Future Plans
  • bioAffinity Technologies' Stock Surges 50%: Key Insights
  • C3.ai Faces Legal Challenges Over Allegations of Misleading Info
  • Vox Royalty Expands with Acquisition of Significant Gold Assets
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site